-
Startseite
-
a-t-Inhaltsverzeichnis
-
a-t-Volltextsuche
für Nichtabonnenten
-
Bereich für Abonnenten
   blitz-a-t
   e a-t
   a-t-Volltextregister
   NETZWERK-UAW
   Leserpost
-
atd Arzneimitteldatenbank
-
Glossar
-
a-t englisch  
   Current issue
   Archive
-
Bestellungen
   arznei-telegramm
   Bücher, CD,
   Sammelmappen
   atd
   Arzneimitteldatenbank
   Mitteilung
   an den Vertrieb
-
Wir über uns
-
Impressum
-
Datenschutz
-
 
 
  Volume 34, 16 May 2003 05/2003
 
  SPOT ON
 

CONVINCE Study: Early Stop for Commercial Reasons Unethical

 
  NEW ON THE MARKET
 

Cox-2 Inhibitor Valdecoxib (BEXTRA)
5-Alpha-Reductase Inhibitor Dutasteride (AVODART) in Benign Prostatic Hyperplasia
Chronic Hepatitis B: Adefovir (HEPSERA)
Miglustat (ZAVESCA) as a Remedy for GAUCHER Disease

 
  REVIEW
 

Treatment of Atopic Dermatitis (II): Further Therapeutic Interventions

 
  a-t READERS' QUESTIONS AND COMMENTS
 

OMACOR After Myocardial Infarction?
Hip Protectors: Importance of Structured Education Questioned

 
  IN BRIEF
 

Menopausal Hormone Replacement Without Effect on Quality of Life

 
  CURRENT ADR NETWORK REPORT
 

Slow-Onset Myopathy Due to Statins
AZUMETOP RETARD Tablets Indigestible

 
  SIDE EFFECTS

Fatalities After Hexavalent Vaccines (HEXAVAC, INFANRIX HEXA)
Homonal Contraceptives and Cervical Cancer
Telithromycin (KETEK): Exacerbation of Myasthenia Gravis

 
© arznei-telegramm 05/2003